It Is Also A Guide To Fentanyl Citrate Injection Formulations UK In 2024
Understanding Fentanyl Citrate Injection Formulations in the UK: A Clinical Overview
Fentanyl citrate remains one of the most vital tools in contemporary anaesthesia and intense discomfort management across the United Kingdom. As a potent artificial opioid, its role in the National Health Service (NHS) and private surgical sectors is reputable, mostly due to its quick start of action and cardiovascular stability. This article offers a detailed overview of fentanyl citrate injection formulations readily available in the UK, their medical signs, regulative landscape, and administration procedures.
What is Fentanyl Citrate?
Fentanyl citrate is a potent phenylpiperidine-derivative opioid agonist. It was very first manufactured in 1960 and rapidly became a foundation of perioperative care. In regards to strength, fentanyl is around 50 to 100 times more powerful than morphine. Its high lipophilicity permits it to cross the blood-brain barrier rapidly, leading to a nearly immediate analgesic impact when administered intravenously.
In the UK, fentanyl citrate is mainly used via the parenteral path (injection) for both sedative and analgesic functions. It works mainly by binding to the mu-opioid receptors in the main worried system, modifying the understanding of pain and the emotional reaction to it.
Scientific Indications in the UK
According to the British National Formulary (BNF), fentanyl citrate injection is shown for numerous particular clinical scenarios:
- Analgesic Action: Used during short personnel treatments and in the healing room.
- Analgesic Supplement: Used during the induction and maintenance of inhalation anaesthesia.
- Neuroleptanalgesia: Often used in mix with a neuroleptic (such as droperidol) to accomplish a state of quiescence and minimized awareness.
- Management of Severe Pain: Particularly in the Intensive Care Unit (ICU) for patients on mechanical ventilation.
- Pre-medication: To supply sedation and analgesia before the induction of basic anaesthesia.
Offered Formulations and Strengths in the UK
The UK market offers several formulations of fentanyl citrate, developed to meet the varying needs of surgical and emergency departments. These are typically provided as clear, colourless services for injection or infusion.
Table 1: Common Fentanyl Citrate Formulations in the UK
| Strength (Fentanyl base) | Presentation | Common Packaging | Maker Examples |
|---|---|---|---|
| 50 micrograms/ml | 2 ml Ampoule | Load of 10 | Hameln, Advanz Pharma |
| 50 micrograms/ml | 10 ml Ampoule | Load of 5 or 10 | Hameln, Wockhardt |
| 50 micrograms/ml | 20 ml Vial/Ampoule | Load of 5 | Hameln, Generic |
| 50 micrograms/ml | 50 ml Vial | Individual/Pack of 1 | Generic (ICU use) |
Note: While 50 mcg/ml is the basic concentration, specialised solutions for epidural or intrathecal usage might often be prepared by health center pharmacies under specific protocols.
Pharmacokinetics and Pharmacodynamics
Comprehending how the body processes fentanyl is important for safe administration.
- Onset of Action: When administered intravenously, the result starts nearly immediately, though the optimum analgesic impact may take 3 to 5 minutes.
- Duration: A single intravenous dosage of 100 micrograms usually lasts for 30 to 60 minutes.
- Metabolism: Fentanyl is primarily metabolised in the liver through the CYP3A4 enzyme system.
- Excretion: Approximately 75% of the dose is excreted in the urine within 24 hours, primarily as metabolites.
Administration Protocols
In the UK, the administration of fentanyl citrate is strictly controlled and generally performed by anaesthetists or trained practitioners in controlled environments.
Dosage Guidelines
Dose must be horizontal and individualised based upon the client's age, weight, physical status, underlying pathological condition, use of other drugs, and the type of surgery.
- Low Dose (2 mcg/kg): Useful for small surgeries.
- Moderate Dose (2-- 20 mcg/kg): Used when surgery is more invasive; requires breathing tracking.
- High Dose (20-- 50 mcg/kg): Used throughout "hassle-free" major surgeries (e.g., open-heart surgery) to safeguard the myocardium from the metabolic demands of stress.
Routes of Administration
- Intravenous (IV) Bolus: Common for induction.
- Intravenous Infusion: Used for longer treatments or in the ICU.
- Intramuscular (IM): Less typical, but used for pre-medication in specific circumstances.
Regulative Status and Safety
In the United Kingdom, Fentanyl is categorized under the Misuse of Drugs Act 1971 as a Class A drug. Under the Misuse of Drugs Regulations 2001, it is categorized as a Schedule 2 Controlled Drug (CD POM).
Statutory Requirements for UK Hospitals:
- Safe Custody: Must be kept in a locked managed drug cupboard.
- Record Keeping: Every administration must be taped in a Controlled Drugs Register (CDR).
- Damage: Surplus or ended fentanyl must be denatured and witnessed by authorised personnel.
Adverse Effects and Adverse Reactions
While extremely efficient, fentanyl citrate carries a threat of considerable negative effects.
- Respiratory Depression: The most severe negative effects, which can result in breathing arrest if not monitored.
- Bradychardia: Often handled with atropine.
- Muscle Rigidity (Chest Wall Rigidity): High doses can make ventilation hard, requiring making use of neuromuscular blocking representatives.
- Nausea and Vomiting: Common in the postoperative duration.
- Hypotension: Although more steady than morphine, it can still take place, particularly in hypovolaemic patients.
Contrast with Other Opioids
Clinicians often pick fentanyl over other opioids due to its specific pharmacokinetic profile.
Table 2: Comparison of Parenteral Opioids in UK Practice
| Feature | Fentanyl | Morphine | Remifentanil |
|---|---|---|---|
| Relative Potency | 100 | 1 | 100-200 |
| Start | 1-- 3 minutes | 15-- 30 minutes | 1 minute |
| Period of Action | 30-- 60 minutes | 3-- 4 hours | 5-- 10 minutes |
| Histamine Release | Minimal | Substantial | Minimal |
| Primary Use | Intraoperative/ICU | Post-operative/Chronic | Titratable Infusion |
Frequently Asked Questions (FAQ)
1. Is fentanyl citrate injection the very same as the fentanyl patches?
No. While they consist of the same active drug, the injection is for immediate, acute usage in surgical or emergency situation settings. Patches (transdermal delivery) are developed for chronic, long-term pain management and release the medication gradually over 72 hours.
2. Can fentanyl citrate be used for children in the UK?
Yes, it is regularly used in paediatric anaesthesia. Nevertheless, the dosage must be strictly calculated based upon the kid's weight, and they must be kept track of closely for respiratory anxiety.
3. What is the villain for fentanyl?
Naloxone is the specific pharmacological antagonist used to reverse the effects of fentanyl, including breathing anxiety. In UK healthcare facilities, naloxone should always be readily offered anywhere fentanyl is administered.
4. Why is it utilized over morphine in heart surgery?
Fentanyl is chosen in heart surgery since it does not trigger the release of histamine, which can cause vasodilation and hypotension. click here provides cardiovascular stability even at high doses.
5. What are the storage requirements?
Fentanyl citrate injection must be saved listed below 25 ° C and protected from light. As a Schedule 2 drug, it must be kept in a legally certified CD cupboard.
Fentanyl citrate injection formulas are essential elements of the UK's medical toolkit for handling perioperative pain and facilitating intricate surgical treatments. Its high strength and rapid onset offer unrivaled accuracy for anaesthetists, supplied that extensive tracking and regulatory requirements are kept. By understanding the numerous concentrations and the rigorous protocols surrounding its use, healthcare professionals ensure that this powerful medication stays both safe and efficient for patients across the country.
Disclaimer: This post is for informative purposes only and does not make up medical advice. Health care specialists must constantly refer to the Summary of Product Characteristics (SmPC) and existing BNF standards for the most updated recommending details.
